While metformin is the preferred initial treatment for type 2 diabetes according to the American Diabetes Association, the consideration of adding a GLP-1 analog is recommended for patients with inadequate diabetes control, indicated by an HbA1c level exceeding 1.5% above the target. The gene discussed is GLP1R; the disease is diabetes mellitus.